Login to Your Account

Will M&A Palooza Follow Flock of IPOs?

By Marie Powers
Staff Writer

Tuesday, July 16, 2013
With the migration of biotechs to the public markets during the second quarter of 2013, Cowen and Co. LLC theorized in its recent biotech quarterly report that merger and acquisition (M&A) activity in the sector might be suppressed this year.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription